{"count": 12, "results": [{"_id": "36147344", "pmid": 36147344, "pmcid": "PMC9486097", "title": "Literature review of the clinical characteristics of metformin-induced hepatotoxicity", "journal": "Front Pharmacol", "authors": ["Wang C", "Deng H", "Xu Y", "Liu Y"], "date": "2022-09-06T00:00:00Z", "doi": "10.3389/fphar.2022.969505", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "969505", "score": 50279.24, "text_hl": "The MeSH terms and keywords were the following: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, hypoglycemic agents, @DISEASE_Chemical_and_Drug_Induced_Liver_Injury @DISEASE_MESH:D056486 @@@hepatitis@@@, hepatotoxicity, @<m>DISEASE_Jaundice</m> @DISEASE_MESH:D007565 @@@jaundice@@@, @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver injury@@@, @DISEASE_Pruritus @DISEASE_MESH:D011537 @@@pruritus@@@, @DISEASE_Cholangitis @DISEASE_MESH:D002761 @@@cholangitis@@@, and @DISEASE_Cholestasis @DISEASE_MESH:D002779 @@@cholestasis@@@. ", "citations": {"NLM": "Wang C, Deng H, Xu Y, Liu Y. Literature review of the clinical characteristics of metformin-induced hepatotoxicity Front Pharmacol. 2022;13():969505. PMID: 36147344", "BibTeX": "@article{36147344, title={Literature review of the clinical characteristics of metformin-induced hepatotoxicity}, author={Wang C and Deng H and Xu Y and Liu Y}, journal={Front Pharmacol}, volume={13}, pages={969505}}"}}, {"_id": "36131291", "pmid": 36131291, "pmcid": "PMC9494837", "title": "A randomised placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE): study protocol", "journal": "Trials", "authors": ["Dunne F", "Newman C", "Devane D", "Smyth A", "Alvarez-Iglesias A", "Gillespie P", "Browne M", "O'Donnell M"], "date": "2022-09-21T00:00:00Z", "doi": "10.1186/s13063-022-06694-y", "meta_date_publication": "2022 Sep 21", "meta_volume": "23", "meta_issue": "1", "meta_pages": "795", "score": 50251.0, "text_hl": "Non-adherence rate of 8% in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group", "citations": {"NLM": "Dunne F, Newman C, Devane D, Smyth A, Alvarez-Iglesias A, Gillespie P, Browne M, O'Donnell M. A randomised placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE): study protocol Trials. 2022 Sep 21;23(1):795. PMID: 36131291", "BibTeX": "@article{36131291, title={A randomised placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE): study protocol}, author={Dunne F and Newman C and Devane D and Smyth A and Alvarez-Iglesias A and Gillespie P and Browne M and O'Donnell M}, journal={Trials}, volume={23}, number={1}, pages={795}}"}}, {"_id": "38124287", "pmid": 38124287, "title": "A meta-analysis of metformin and insulin on maternal outcome and neonatal outcome in patients with gestational diabetes mellitus.", "journal": "J Matern Fetal Neonatal Med", "authors": ["Wu R", "Zhang Q", "Li Z"], "date": "2024-12-01T00:00:00Z", "doi": "10.1080/14767058.2023.2295809", "meta_date_publication": "2024 Dec", "meta_volume": "37", "meta_issue": "1", "meta_pages": "2295809", "score": 50240.89, "text_hl": "A meta-analysis of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @GENE_INS @GENE_3630 @@@insulin@@@ on maternal outcome and neonatal outcome in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@gestational diabetes mellitus@@@.", "citations": {"NLM": "Wu R, Zhang Q, Li Z. A meta-analysis of metformin and insulin on maternal outcome and neonatal outcome in patients with gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2024 Dec;37(1):2295809. PMID: 38124287", "BibTeX": "@article{38124287, title={A meta-analysis of metformin and insulin on maternal outcome and neonatal outcome in patients with gestational diabetes mellitus.}, author={Wu R and Zhang Q and Li Z}, journal={J Matern Fetal Neonatal Med}, volume={37}, number={1}, pages={2295809}}"}}, {"_id": "9867572", "pmid": 9867572, "title": "Metformin-induced hemolysis with jaundice.", "journal": "N Engl J Med", "authors": ["Lin KD", "Lin JD", "Juang JH"], "date": "1998-12-17T00:00:00Z", "doi": "10.1056/NEJM199812173392517", "meta_date_publication": "1998 Dec 17", "meta_volume": "339", "meta_issue": "25", "meta_pages": "1860-1", "score": 50080.68, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-induced @DISEASE_Hemolysis @DISEASE_MESH:D006461 @@@hemolysis@@@ with @<m>DISEASE_Jaundice</m> @DISEASE_MESH:D007565 @@@jaundice@@@.", "citations": {"NLM": "Lin KD, Lin JD, Juang JH. Metformin-induced hemolysis with jaundice. N Engl J Med. 1998 Dec 17;339(25):1860-1. PMID: 9867572", "BibTeX": "@article{9867572, title={Metformin-induced hemolysis with jaundice.}, author={Lin KD and Lin JD and Juang JH}, journal={N Engl J Med}, volume={339}, number={25}, pages={1860-1}}"}}, {"_id": "11467664", "pmid": 11467664, "title": "Cholestatic jaundice associated with the use of metformin.", "journal": "Am J Gastroenterol", "authors": ["Desilets DJ", "Shorr AF", "Moran KA", "Holtzmuller KC"], "date": "2001-07-01T00:00:00Z", "doi": "10.1111/j.1572-0241.2001.03972.x", "meta_date_publication": "2001 Jul", "meta_volume": "96", "meta_issue": "7", "meta_pages": "2257-8", "score": 50065.91, "text_hl": "Given the onset of his @<m>DISEASE_Jaundice</m> @DISEASE_MESH:D007565 @@@jaundice@@@ 2 wk after the initiation of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, we believe that this case represents an example of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-associated hepatotoxicity, the first such case reported.", "citations": {"NLM": "Desilets DJ, Shorr AF, Moran KA, Holtzmuller KC. Cholestatic jaundice associated with the use of metformin. Am J Gastroenterol. 2001 Jul;96(7):2257-8. PMID: 11467664", "BibTeX": "@article{11467664, title={Cholestatic jaundice associated with the use of metformin.}, author={Desilets DJ and Shorr AF and Moran KA and Holtzmuller KC}, journal={Am J Gastroenterol}, volume={96}, number={7}, pages={2257-8}}"}}, {"_id": "24296614", "pmid": 24296614, "pmcid": "PMC5586851", "title": "Metformin-Induced Hemolytic Anemia", "journal": "Med Princ Pract", "authors": ["Kirkiz S", "Yarali N", "Arman Bilir O", "Tunc B"], "date": "2014-01-01T00:00:00Z", "doi": "10.1159/000356149", "meta_date_publication": "2014", "meta_volume": "23", "meta_issue": "2", "meta_pages": "183-5", "score": 50062.742, "text_hl": "Drug-induced @DISEASE_Anemia_Hemolytic @DISEASE_MESH:D000743 @@@hemolytic anemia@@@ was suspected and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was discontinued, after which the @<m>DISEASE_Jaundice</m> @DISEASE_MESH:D007565 @@@jaundice@@@ disappeared in 3-4 days and therefore there was no requirement for RBC transfusions (fig 1). ", "citations": {"NLM": "Kirkiz S, Yarali N, Arman Bilir O, Tunc B. Metformin-Induced Hemolytic Anemia Med Princ Pract. 2014;23(2):183-5. PMID: 24296614", "BibTeX": "@article{24296614, title={Metformin-Induced Hemolytic Anemia}, author={Kirkiz S and Yarali N and Arman Bilir O and Tunc B}, journal={Med Princ Pract}, volume={23}, number={2}, pages={183-5}}"}}, {"_id": "16503324", "pmid": 16503324, "title": "Possible metformin-induced hepatotoxicity.", "journal": "Am J Geriatr Pharmacother", "authors": ["Kutoh E"], "date": "2005-12-01T00:00:00Z", "meta_date_publication": "2005 Dec", "meta_volume": "3", "meta_issue": "4", "meta_pages": "270-3", "score": 50059.535, "text_hl": "METHODS: After receiving @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 500 mg/d for 3 weeks, a 73-year-old Japanese @SPECIES_9606 @@@woman@@@ weighing 33.5 kg with poorly controlled @DISEASE_Myotonic_Dystrophy @DISEASE_MESH:D009223 @@@DM-2@@@ presented with @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@, @<m>DISEASE_Jaundice</m> @DISEASE_MESH:D007565 @@@jaundice@@@, @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, @DISEASE_Anorexia @DISEASE_MESH:D000855 @@@anorexia@@@, and @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@. ", "citations": {"NLM": "Kutoh E. Possible metformin-induced hepatotoxicity. Am J Geriatr Pharmacother. 2005 Dec;3(4):270-3. PMID: 16503324", "BibTeX": "@article{16503324, title={Possible metformin-induced hepatotoxicity.}, author={Kutoh E}, journal={Am J Geriatr Pharmacother}, volume={3}, number={4}, pages={270-3}}"}}, {"_id": "14561576", "pmid": 14561576, "title": "Metformin-induced cholestatic hepatitis.", "journal": "Endocr Pract", "authors": ["Nammour FE", "Fayad NF", "Peikin SR"], "date": "2003-07-01T00:00:00Z", "doi": "10.4158/EP.9.4.307", "meta_date_publication": "2003 Jul-Aug", "meta_volume": "9", "meta_issue": "4", "meta_pages": "307-9", "score": 50059.355, "text_hl": "The dosage initially was 500 mg twice daily and later was increased to 850 mg twice a day. Four weeks after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@met-formin@@@ treatment was initiated, @<m>DISEASE_Jaundice</m> @DISEASE_MESH:D007565 @@@jaundice@@@, @DISEASE_Pruritus @DISEASE_MESH:D011537 @@@pruritus@@@, and @DISEASE_Chemical_and_Drug_Induced_Liver_Injury @DISEASE_MESH:D056486 @@@liver enzyme abnormalities@@@ were noted. ", "citations": {"NLM": "Nammour FE, Fayad NF, Peikin SR. Metformin-induced cholestatic hepatitis. Endocr Pract. 2003 Jul-Aug;9(4):307-9. PMID: 14561576", "BibTeX": "@article{14561576, title={Metformin-induced cholestatic hepatitis.}, author={Nammour FE and Fayad NF and Peikin SR}, journal={Endocr Pract}, volume={9}, number={4}, pages={307-9}}"}}, {"_id": "18783609", "pmid": 18783609, "pmcid": "PMC2546413", "title": "Fatal hemolytic anemia associated with metformin: A case report", "journal": "J Med Case Rep", "authors": ["Packer CD", "Hornick TR", "Augustine SA"], "date": "2008-09-10T00:00:00Z", "doi": "10.1186/1752-1947-2-300", "meta_date_publication": "2008 Sep 10", "meta_volume": "2", "meta_issue": "", "meta_pages": "300", "score": 50058.195, "text_hl": "Fatal @DISEASE_Anemia_Hemolytic @DISEASE_MESH:D000743 @@@hemolytic anemia@@@ associated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@: A case report", "citations": {"NLM": "Packer CD, Hornick TR, Augustine SA. Fatal hemolytic anemia associated with metformin: A case report J Med Case Rep. 2008 Sep 10;2():300. PMID: 18783609", "BibTeX": "@article{18783609, title={Fatal hemolytic anemia associated with metformin: A case report}, author={Packer CD and Hornick TR and Augustine SA}, journal={J Med Case Rep}, volume={2}, pages={300}}"}}, {"_id": "23983487", "pmid": 23983487, "pmcid": "PMC3751382", "title": "Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review", "journal": "Int J Gen Med", "authors": ["Saadi T", "Waterman M", "Yassin H", "Baruch Y"], "date": "2013-08-19T00:00:00Z", "doi": "10.2147/IJGM.S49657", "meta_date_publication": "2013", "meta_volume": "6", "meta_issue": "", "meta_pages": "703-6", "score": 50052.49, "text_hl": "He had also had @DISEASE_Pruritus @DISEASE_MESH:D011537 @@@pruritus@@@ and @<m>DISEASE_Jaundice</m> @DISEASE_MESH:D007565 @@@jaundice@@@ for 8 days. @DISEASE_Myotonic_Dystrophy @DISEASE_MESH:D009223 @@@DM-2@@@ had been recently diagnosed and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 850 mg/day had been initiated 2 weeks before presentation to the hospital. ", "citations": {"NLM": "Saadi T, Waterman M, Yassin H, Baruch Y. Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review Int J Gen Med. 2013;6():703-6. PMID: 23983487", "BibTeX": "@article{23983487, title={Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review}, author={Saadi T and Waterman M and Yassin H and Baruch Y}, journal={Int J Gen Med}, volume={6}, pages={703-6}}"}}]}